Prolgolimab, CAS 2093956-19-3

Product Description: Prolgolimab (BCD-100) is a human IgG1 anti-PD-1 monoclonal antibody containing the Fc-silencing 'LALA' mutation. Prolgolimab can be used for the research of advanced melanoma[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Tjulandin S, et, al. Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice. Eur J Cancer. 2021 May;149:222-232.

CAS Number: 2093956-19-3

Molecular Weight: N/A

Research Area: Cancer

Solubility: H2O

Target: PD-1/PD-L1

• SKU: MEXHY-P99807-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99807-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated